Principal Financial Group Inc. Has $383,000 Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Principal Financial Group Inc. cut its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 31.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,072 shares of the company’s stock after selling 8,194 shares during the quarter. Principal Financial Group Inc.’s holdings in Oscar Health were worth $383,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. State Street Corp increased its position in shares of Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares during the period. Geode Capital Management LLC boosted its position in shares of Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after acquiring an additional 455,205 shares in the last quarter. Renaissance Technologies LLC increased its stake in Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after acquiring an additional 934,600 shares during the period. Charles Schwab Investment Management Inc. raised its position in Oscar Health by 20.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after purchasing an additional 270,223 shares in the last quarter. Finally, Westfield Capital Management Co. LP acquired a new stake in Oscar Health during the third quarter valued at approximately $27,452,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Trading Up 5.9 %

Shares of NYSE OSCR opened at $14.35 on Monday. Oscar Health, Inc. has a fifty-two week low of $8.44 and a fifty-two week high of $23.79. The firm has a market capitalization of $3.55 billion, a P/E ratio of -239.13 and a beta of 1.63. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company’s 50 day simple moving average is $15.28 and its 200 day simple moving average is $16.99.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s quarterly revenue was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.29) earnings per share. On average, analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Piper Sandler restated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective on the stock. Finally, UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Two analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $21.56.

Insiders Place Their Bets

In related news, CFO Richard Scott Blackley sold 25,279 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $457,044.32. Following the completion of the transaction, the chief financial officer now directly owns 881,841 shares of the company’s stock, valued at approximately $15,943,685.28. This represents a 2.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.